Condensed Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2018	Dec. 31, 2017
Current assets:
Cash	$ 233	$ 1,115
Other prepaid expenses and current assets	171	22
Total current assets	404	1,137
Property and equipment, net		2
Other assets	33	33
Total assets	437	1,172
Current liabilities:
Accounts payable	1,164	788
Accrued compensation and employee benefits	23	73
Accrued clinical trial expenses	90	509
Other accrued liabilities	247	279
Total current liabilities	1,524	1,649
Commitments and contingencies
Stockholders' equity/(deficit):
Preferred stock, $0.01 par value, 15,000 shares authorized; No shares issued and outstanding
Common stock, $0.01 par value, 70,000 shares authorized; 26,545 shares issued and outstanding	265	265
Additional paid-in capital	291,717	291,533
Accumulated deficit	(293,069)	(292,275)
Total stockholders' deficit	(1,087)	(477)
Total liabilities and stockholders' deficit	$ 437	$ 1,172